The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer

Annals of Thoracic and Cardiovascular Surgery

Volumn 13, Issue 2, 2007, Pages 73-77

  Tsuboi, Masahiro ^a   Ohira, Tatsuo ^a   Saji, Hisashi ^a   Miyajima, Kuniharu ^a   Kajiwara, Naohiro ^a   Uchida, Osamu ^a   Usuda, Jitsuo ^a   Kato, Harubumi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adjuvant chemotherapy; Complete resection; Meta analysis; Non small cell lung cancer; Postoperative treatment; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; PACLITAXEL;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MORTALITY; PHASE 3 CLINICAL TRIAL; REVIEW; SURVIVAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III; HUMANS; LUNG NEOPLASMS; PACLITAXEL; SURVIVAL ANALYSIS;

EID: 34250372612     PISSN: 13411098     EISSN: 21861005     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005; 50: 227-34.
2. Mountain CF. Revisions in international system for staging lung cancer. Chest 1997; 111: 1710-7.
3. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a metaanalysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
4. Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003; 95: 1453-61.
5. Waller D, Peake MD, Stephens RJ, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004; 26: 173-82.
6. Arriagada R, Bergman B, Dunant A, et al. Cisplatinbased adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-60.
7. Winton TL, Livingstan R, Johnson D, et al. A prospective randomized trial of adjuvant vinorelbine (VNR) and cisplatin (CIS) in completely resected stage Ib and II non small cell lung cancer (NSCLC) Intergroup JBR 10. N Engl J Med 2005; 352: 2589-97.
8. Strauss GM, Hernden J, Maddaus MA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage Ib Non-Small Cell Lung Cancer (NSCLC): Report of cancer and leukemia group B (CALGB) protocol 9633. J Clin Oncol 2004; 22: 621s (abstr. #7019).
9. Strauss GM, Hernden J, Maddaus MA, et al. Adjuvant chemotherapy in Stage IB non-small cell lung cancer (NSCLC): update on Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 2006; 24 (18 Suppl): 365s (abstr. #7007).
10. Douillard J, Rosell R, Delena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006; 7: 719-27.
11. Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med 2004; 350: 1713-21.
12. Hamada C, Tanaka F, Ohta M, et al. Meta-analysis of postoperative adjuvant chemotherapy with tegafururacil in non-small-cell lung cancer. J Clin Oncol 2005; 23: 4999-5006.
13. Ho D, Pazdur R, Covington W, et al. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouraccil infusion and oral uracil plus N1-(2́-tetrahyfrofuryl)-5-fluorouracil. Clin Cancer Res 1998; 4: 2085-8.
14. Comets E, Ikeda K, Hoff P, et al. Comparison of the pharmacokinetics of S-1, an oral anti-cancer agent, in Western and Japanese patients. J Pharmacokinet Pharmacodyn 2003; 30: 257-83.
15. Hotta K, Matsuo K, Ueoka H, et al. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004; 22: 3860-7.
16. Sedrakyan A, van Der Meulen J, O'Byrne K, et al. Psotoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004; 128: 414-419
17. Pignon JP, Triboder GV, Scagliotti G, et al. Lung Adjuvant Cisplatin Evaluation (LACE): a pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 2006; 24 (18 Suppl): 366s (abstr. #7008).
18. Tsuboi M, Kato H, Nagai K, et al. Gefitinib in the adjuvant setting: safety results from a phase III study in patients with completely resected non-small cell lung cancer. Anticancer Drugs 2005; 16: 1123-8.